WORCESTER, Mass., Aug. 28, 2008 (GLOBE NEWSWIRE) (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is featured in an interview segment on Business News Network (BNN)'s "Power Breakfast" regarding Generex Oral-lyn(tm), the company's flagship proprietary oral insulin spray product.
